New modified -human chorionic gonadotropin proteins; HCG protein engineering and expression in a mammal or microorganism cell, for use as a contraceptive and antitumor recombinant vaccine, or a nucleic acid vaccine

By Roitt I.   Delves P.  

Vaccine, Vol. 15, Iss. 8, 1997-06 ,pp. : 935-935

Elsevier

Access to resources Recommend Favorite

Recombinant pox virus containing sequence encoding myelin protein and infected cells for use in inflammatory demyelinizing disease diagnosis, therapy, gene therapy and recombinant vaccine

By  

Vaccine, Vol. 16, Iss. 7, 1998-04 ,pp. : 757-757

Elsevier

Access to resources Recommend Favorite

Mucosal binding compositions for generating mucosal immune response; Chlamydia, HIV virus, hepatitis B virus or enterotoxigenic Escherichia coli antigen and cholera toxin binding subunit fusion protein expression, for use as a recombinant vaccine

By Lebens M.   Holmgren J.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1299-1299

Elsevier

Access to resources Recommend Favorite

A live attenuated recombinant chimeric parainfluenza virus (PIV) candidate vaccine containing the hemagglutinin-neuraminidase and fusion glycoproteins of PIV1 and the remaining proteins from PIV3 induces resistance to PIV1 even in animals immune to P

By Tao T.   Davoodi F.   Cho C.J.   Skiadopoulos M.H.   Durbin A.P.   Collins P.L.   Murphy B.R.  

Vaccine, Vol. 18, Iss. 14, 2000-02 ,pp. : 1359-1366

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation

By Jacquet A.   Haumont M.   Massaer M.   Garcia L.   Mazzu P.   Daminet V.   Gregoire D.   Jacobs P.   Bollen A.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1593-1602

Elsevier

Access to resources Recommend Favorite